90 related articles for article (PubMed ID: 3327806)
1. Prevention of murine cerebral malaria by low-dose cyclosporin A.
Grau GE; Gretener D; Lambert PH
Immunology; 1987 Aug; 61(4):521-5. PubMed ID: 3327806
[TBL] [Abstract][Full Text] [Related]
2. Antimalarial effect of cyclosporin-A on murine P. berghei and human P. falciparum.
Biswas S; Saxena QB; Upender M
Indian J Malariol; 1991 Mar; 28(1):1-8. PubMed ID: 1915980
[TBL] [Abstract][Full Text] [Related]
3. L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria.
Grau GE; Piguet PF; Engers HD; Louis JA; Vassalli P; Lambert PH
J Immunol; 1986 Oct; 137(7):2348-54. PubMed ID: 3093572
[TBL] [Abstract][Full Text] [Related]
4. Plasmodium berghei XAT: contribution of gammadelta T cells to host defense against infection with blood-stage nonlethal malaria parasite.
Kobayashi F; Niikura M; Waki S; Matsui T; Fujino T; Tsuruhara T; Kamiya S
Exp Parasitol; 2007 Dec; 117(4):368-75. PubMed ID: 17601562
[TBL] [Abstract][Full Text] [Related]
5. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei.
White KL; Snyder HL; Krzych U
J Immunol; 1996 May; 156(9):3374-81. PubMed ID: 8617963
[TBL] [Abstract][Full Text] [Related]
6. The immunomodulatory effect of Sambucol on leishmanial and malarial infections.
Waknine-Grinberg JH; El-On J; Barak V; Barenholz Y; Golenser J
Planta Med; 2009 May; 75(6):581-6. PubMed ID: 19214946
[TBL] [Abstract][Full Text] [Related]
7. Antioxidants can prevent cerebral malaria in Plasmodium berghei-infected mice.
Thumwood CM; Hunt NH; Cowden WB; Clark IA
Br J Exp Pathol; 1989 Jun; 70(3):293-303. PubMed ID: 2669924
[TBL] [Abstract][Full Text] [Related]
8. Protective immunity against Plasmodium berghei malaria after administration of interleukin-12.
Normaznah Y; Halim AA; Outhayphone M; Zamri MR
Malays J Pathol; 1999 Dec; 21(2):123-5. PubMed ID: 11068418
[TBL] [Abstract][Full Text] [Related]
9. Prevention of cerebral malaria by adoptive transfer of malaria-specific cultured T cells into mice infected with Plasmodium berghei.
Finley R; Weintraub J; Louis JA; Engers HD; Zubler R; Lambert PH
J Immunol; 1983 Sep; 131(3):1522-6. PubMed ID: 6224859
[TBL] [Abstract][Full Text] [Related]
10. Artesunate-erythropoietin combination for murine cerebral malaria treatment.
Bienvenu AL; Ferrandiz J; Kaiser K; Latour C; Picot S
Acta Trop; 2008 May; 106(2):104-8. PubMed ID: 18359468
[TBL] [Abstract][Full Text] [Related]
11. Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites.
Leitner WW; Seguin MC; Ballou WR; Seitz JP; Schultz AM; Sheehy MJ; Lyon JA
J Immunol; 1997 Dec; 159(12):6112-9. PubMed ID: 9550412
[TBL] [Abstract][Full Text] [Related]
12. Thalidomide influences the function of macrophages and increases the survival of Plasmodium berghei-infected CBA mice.
Muniz-Junqueira MI; Silva FO; de Paula-Júnior MR; Tosta CE
Acta Trop; 2005 May; 94(2):128-38. PubMed ID: 15817259
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of indoleamine 2,3-dioxygenase in murine malaria infection is predominantly localised to the vascular endothelium.
Hansen AM; Ball HJ; Mitchell AJ; Miu J; Takikawa O; Hunt NH
Int J Parasitol; 2004 Nov; 34(12):1309-19. PubMed ID: 15542091
[TBL] [Abstract][Full Text] [Related]
14. Protection against cerebral malaria by the low-molecular-weight thiol pantethine.
Penet MF; Abou-Hamdan M; Coltel N; Cornille E; Grau GE; de Reggi M; Gharib B
Proc Natl Acad Sci U S A; 2008 Jan; 105(4):1321-6. PubMed ID: 18195363
[TBL] [Abstract][Full Text] [Related]
15. [Plasmodium berghei: antibody response and protective immunity induced by vaccination].
Casaglia O; Zenobi P; Bucci A; Stiffel C; Biozzi G
Parassitologia; 1982 Dec; 24(2-3):121-7. PubMed ID: 6765341
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium berghei: cerebral malaria in CBA mice is not clearly related to plasma TNF levels or intensity of histopathological changes.
Carvalho LJ; Lenzi HL; Pelajo-Machado M; Oliveira DN; Daniel-Ribeiro CT; Ferreira-da-Cruz MF
Exp Parasitol; 2000 May; 95(1):1-7. PubMed ID: 10864512
[TBL] [Abstract][Full Text] [Related]
17. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria.
Sanni LA; Thomas SR; Tattam BN; Moore DE; Chaudhri G; Stocker R; Hunt NH
Am J Pathol; 1998 Feb; 152(2):611-9. PubMed ID: 9466588
[TBL] [Abstract][Full Text] [Related]
18. Adoptive transfer of immunity to Plasmodium berghei with spleen cells from drug cured mice.
Yadav M; Sidhu AS
Southeast Asian J Trop Med Public Health; 1982 Jun; 13(2):186-95. PubMed ID: 6755741
[TBL] [Abstract][Full Text] [Related]
19. Effects of DNA vaccine in murine malaria using a full-length cDNA library.
Shibui A; Ohmori Y; Suzuki Y; Sasaki M; Nogami S; Sugano S; Watanabe J
Res Commun Mol Pathol Pharmacol; 2001; 109(3-4):147-57. PubMed ID: 11758646
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
Rotman HL; Daly TM; Long CA
Exp Parasitol; 1999 Jan; 91(1):78-85. PubMed ID: 9920045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
